Spironolactone
Product Images NDC 53808-0796

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 53808-0796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Spironolactone 25mg(actavis))

Spironolactone 25 mg tablets label indicating a quantity of 30 tablets. The label includes the lot number, expiration date, and states it is for prescription use only. It is packaged by the State of Florida DOH Central Pharmacy in Tallahassee, FL 32304. A UPC barcode is also visible.*

FDA Label Image

Graph 1 (Proposed Tmp2009518143155207)

A survival plot comparing outcomes between two groups labeled 'Placebo' and 'Spironolactone.' The y-axis represents the probability P(t) from 0.0 to 1.0, and the x-axis shows time in months up to 48. The graph illustrates a decreasing survival probability over time for both groups, with Spironolactone showing lower survival probability than Placebo. A log-rank test p-value is noted as <0.001.*

FDA Label Image

Graph 2 (Proposed Tmp2009518143155332)

A forest plot chart showing subgroup analysis of hazard ratios (HR) with 95% confidence intervals (CI) for various patient characteristics comparing Spironolactone versus placebo. The x-axis ranges from 0.2 to 1.4, indicating effect size favoring Spironolactone on the left and placebo on the right. Data points include subgroups by age, sex, race, liver function, presence of atrial fibrillation, stroke, diabetes, kidney function, potassium levels, medication use, and presence of gastrointestinal bleeding, among others. The plot visually summarizes the comparative efficacy or safety outcomes across these subgroups.*

FDA Label Image

Imprint 1 (Proposed Tmp2009518143155472)

Spironolactone 25 mg tablets packaging label from State of Florida DOH Central Pharmacy. The white bottle with a white cap displays the product name and strength clearly on the front. The label also includes the labeler information and product NDC: 53808-0796.*

FDA Label Image

Imprint 2 (Proposed Tmp2009518143155535)

FDA Label Image

Imprint 3 (Proposed Tmp2009518143155582)

Spironolactone bottle label by State of Florida DOH Central Pharmacy, showing drug name prominently. The label includes a logo with an orange flower and medical symbols. The image displays the container's front with important identification details but does not show strength, dosage form, or package size clearly.*

FDA Label Image

Structural Formula (Proposed Tmp200951814315597)

Chemical structure of spironolactone showing its molecular framework with labeled carbon, hydrogen, oxygen, and sulfur atoms. The image includes a molecular weight indication of 416.57.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.